Estrella Immunopharma, Inc. financial statements
Estrella Immunopharma, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Net income | −USD 13.06M | 10-K |
| Cash and equivalents | USD 1.38M | 10-K |
Estrella Immunopharma, Inc. financials on 6ix · Estrella Immunopharma, Inc. on 6ix